Flu season forecasts could be more accurate with access to health care companies’ data

In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could—if made available to researchers and public health agencies—enable more accurate forecasts of when the next flu season will peak, how long it will last and how many people will […]

Continue reading »

Effective drug delivery to heart with tannic acid

Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research team developed a heart-targeting drug delivery technology using tannin acid via intravenous systemic injection. This method can be applied to the development of a variety of new protein-based […]

Continue reading »

Repeat vaccination is safe for most kids with mild to moderate reactions

Children who experience some type of adverse event following initial immunization have a low rate of recurrent reactions to subsequent vaccinations, reports a study in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. “Most patients with a history of mild or moderate adverse events following immunization [AEFI] can be safely reimmunized,” write […]

Continue reading »

Patients with sepsis at higher risk of stroke, heart attack after hospital discharge

Patients with sepsis are at increased risk of stroke or myocardial infarction (heart attack) in the first 4 weeks after hospital discharge, according to a large Taiwanese study published in CMAJ (Canadian Medical Association Journal). Sepsis accounts for an estimated 8 million deaths worldwide, and in Canada causes more than half of all deaths from infectious diseases. Researchers looked at […]

Continue reading »

Remission of schizophrenia seen with amisulpride, clozapine

(HealthDay)—Remission can be achieved for most cases of schizophrenia and schizophreniform disorder with amisulpride and clozapine, according to a study published online Aug. 13 in the The Lancet Psychiatry. René S. Kahn, M.D., from Brain Center Rudolf Magnus in Utrecht, Netherlands, and colleagues recruited 481 participants from 27 centers in 14 European countries and Israel. Patients aged 18 to 40 […]

Continue reading »

Patients with new-onset AFib after TAVR at highest risk for complications

Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR. Transcatheter aortic valve replacement (TAVR) is a […]

Continue reading »

Study links aortic stiffness with lower cerebral blood flow

Greater aortic stiffness is related to lower cerebral blood flow, especially among individuals with increased genetic predisposition to Alzheimer’s disease, according to research from Vanderbilt University Medical Center. The study, published recently in Circulation, supports emerging evidence that arterial stiffness, a hypertension-related factor, may play a role in cognitive decline, said Angela Jefferson, Ph.D., professor of Neurology and director of […]

Continue reading »

Effects of deep brain stimulation in patients with Parkinson’s disease

Researchers at Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson’s disease. Their results show that the adverse cognitive effects of deep brain stimulation are linked to a different neural pathway than that responsible for the treatment’s desired motor effects. This finding will help optimize treatments for patients with Parkinson’s disease. Results from […]

Continue reading »
1 14 15 16 17 18 26